Seth Hollander
Publication Details
-
B-type natriuretic peptide levels predict outcome after neonatal cardiac surgery.
J Thorac Cardiovasc Surg. 2007; (4): 939-45
Neonates undergoing cardiac surgery are at high risk for adverse outcomes. B-type natriuretic peptide is used as a biomarker in patients with cardiac disease, but the predictive value of B-type natriuretic peptide after cardiac surgery in neonates has not been evaluated. Therefore, the objective of this study was to determine the predictive value of perioperative B-type natriuretic peptide levels for postoperative outcomes in neonates undergoing cardiac surgery.
